Pure Global

PRUEBA RÁPIDA PARA DETECCIÓN DE CREATINA QUINASA - COFEPRIS Registration 0362R2022 SSA

Access comprehensive regulatory information for PRUEBA RÁPIDA PARA DETECCIÓN DE CREATINA QUINASA (PRUEBA RÁPIDA PARA DETECCIÓN DE CREATINA QUINASA) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0362R2022 SSA and manufactured by DIINSEL, S.A. DE C.V.. The device was registered on May 12, 2022.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase I
0362R2022 SSA
PRUEBA RÁPIDA PARA DETECCIÓN DE CREATINA QUINASA
COFEPRIS Analysis ID: 0362R2022 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase I
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
CREATINE KINASE-MB RAPID TEST
Trade Name (English)
CREATINE KINASE-MB RAPID TEST
Registration Information
Analysis ID
0362R2022 SSA
Registration Date
May 12, 2022
Manufacturer / Fabricante
Name (Spanish)
DIINSEL, S.A. DE C.V.
Name (English)
DIINSEL, S.A. DE C.V.